{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:08:27Z","timestamp":1793610507564,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.phrs.2023.106904","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T01:01:56Z","timestamp":1693789316000},"page":"106904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"196","author":[{"given":"Chengming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-4459","authenticated-orcid":false,"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9735","key":"10.1016\/j.phrs.2023.106904_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106904_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106292","article-title":"Redoxisome and diabetic retinopathy: pathophysiology and therapeutic interventions","volume":"182","author":"Sharma","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106904_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101357","article-title":"Prevalence of restless legs syndrome in people with diabetes mellitus: a pooling analysis of observational studies","volume":"46","author":"Ning","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.phrs.2023.106904_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115643","article-title":"Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation","volume":"214","author":"Chen","year":"2023","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-020-01202-5","article-title":"Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc Diabetol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106904_bib6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phrs.2023.106904_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106559","article-title":"Aquaporin 11 alleviates retinal M\u00fcller intracellular edema through water efflux in diabetic retinopathy","volume":"187","author":"Zhang","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106904_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin Eye Res"},{"issue":"10","key":"10.1016\/j.phrs.2023.106904_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11892-019-1210-x","article-title":"Surgical innovations in the treatment of diabetic macular edema and diabetic retinopathy","volume":"19","author":"Berrocal","year":"2019","journal-title":"Curr. Diab Rep."},{"issue":"7","key":"10.1016\/j.phrs.2023.106904_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159553","article-title":"The efficacy and safety of current treatments in diabetic macular edema: a systematic review and network meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.phrs.2023.106904_bib12","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02713680490513191","article-title":"Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life","volume":"29","author":"Tranos","year":"2004","journal-title":"Curr. Eye Res"},{"issue":"9","key":"10.1016\/j.phrs.2023.106904_bib14","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1080\/02713683.2021.1884729","article-title":"Exposure of contralateral eyes to laser radiation during retinal photocoagulation","volume":"46","author":"Gauldin","year":"2021","journal-title":"Curr. Eye Res"},{"key":"10.1016\/j.phrs.2023.106904_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104299","article-title":"and D.P. C, Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.","volume":"147","author":"Narayanan","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106904_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/pharmaceutics13081137","article-title":"Intravitreal anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy: a review of the literature","volume":"13","author":"Chatziralli","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2023.106904_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phrs.2015.05.013","article-title":"Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy","volume":"99","author":"Behl","year":"2015","journal-title":"Pharm. Res"},{"issue":"12","key":"10.1016\/j.phrs.2023.106904_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00592-019-01416-4","article-title":"Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results","volume":"56","author":"Busch","year":"2019","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.phrs.2023.106904_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104924","article-title":"Hypoxia-inducible factor-1\u03b1: a promising therapeutic target for vasculopathy in diabetic retinopathy","volume":"159","author":"Li","year":"2020","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1389203719666180928123449","article-title":"Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways","volume":"20","author":"Sahajpal","year":"2019","journal-title":"Curr. Protein Pept. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2023.106904_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11892-020-01308-w","article-title":"Updates on gene therapy for diabetic retinopathy","volume":"20","author":"Wang","year":"2020","journal-title":"Curr. Diab Rep."},{"issue":"8","key":"10.1016\/j.phrs.2023.106904_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1248\/bpb.31.1541","article-title":"Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000284466","article-title":"Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema","volume":"224","author":"Kreutzer","year":"2010","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2015.12.012","article-title":"Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)","volume":"123","author":"Fraser-Bell","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.phrs.2023.106904_bib25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ophtha.2009.02.002","article-title":"Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review","volume":"116","author":"Yilmaz","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12886-023-02790-y","article-title":"Suprachoroidal injection of triamcinolone acetonide plus intravitreal bevacizumab in diabetic macular edema: a randomized pilot trial","volume":"23","author":"Fazel","year":"2023","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40265-021-01665-0","article-title":"Association of metformin with the mortality and incidence of cardiovascular events in patients with pre-existing cardiovascular diseases","volume":"82","author":"Li","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2023.106904_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yfrne.2018.06.004","article-title":"Exogenous melatonin as a treatment for secondary sleep disorders: a systematic review and meta-analysis","volume":"52","author":"Li","year":"2019","journal-title":"Front Neuroendocr."},{"issue":"7","key":"10.1016\/j.phrs.2023.106904_bib29","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1212\/WNL.0000000000012415","article-title":"Association of metabolic syndrome and its components with risk of stroke recurrence and mortality: a meta-analysis","volume":"97","author":"Zhang","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2023.106904_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101559","article-title":"Decompression alone or decompression and fusion in degenerative lumbar spondylolisthesis","volume":"51","author":"Wei","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib31","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/WNL.0000000000011264","article-title":"Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies","volume":"96","author":"Zhang","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2023.106904_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920987650","article-title":"miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients","volume":"13","author":"Zhao","year":"2021","journal-title":"Ther. Adv. Med Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.phrs.2023.106904_bib34","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"key":"10.1016\/j.phrs.2023.106904_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1475-1313.2010.00766.x","article-title":"Transforming scales of measurement of visual acuity at the group level","volume":"30","author":"Khoshnood","year":"2010","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.phrs.2023.106904_bib37","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"issue":"9","key":"10.1016\/j.phrs.2023.106904_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bjophthalmol-2017-310483","article-title":"Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema","volume":"102","author":"Gerendas","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib40","first-page":"209","article-title":"Comparison of Percutaneous Vertebroplasty and Balloon Kyphoplasty for the Treatment of Single Level Vertebral Compression Fractures: A Meta-analysis of the Literature","volume":"18","author":"Wang","year":"2015","journal-title":"Pain. Physician"},{"issue":"7109","key":"10.1016\/j.phrs.2023.106904_bib41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"issue":"20","key":"10.1016\/j.phrs.2023.106904_bib42","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat. Med"},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib43","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"10.1016\/j.phrs.2023.106904_bib45","first-page":"1","article-title":"Intravitreal Ranibizumab and Dexamethasone Implant Injections as primary treatment of diabetic macular edema: the month 24 Results from Simultaneously Double Protocol","author":"Kaya","year":"2023","journal-title":"Curr. Eye Res"},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00592-021-01824-5","article-title":"Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema","volume":"59","author":"Lin","year":"2022","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jfo.2020.08.033","article-title":"Early effect of simultaneous intravitreal dexamethasone and bevacizumab combination treatment in patients with persistent diabetic macular edema","volume":"44","author":"Limon","year":"2021","journal-title":"J. Fr. Ophtalmol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41433-020-0949-2","article-title":"Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol","volume":"35","author":"Kaya","year":"2021","journal-title":"Eye (Lond. )"},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib49","first-page":"229","article-title":"Intravitreal ranibizumab versus intravitreal ranibizumab combined with posterior subtenon triamcinolone acetonide in diabetic macular edema","volume":"6","author":"Karatas","year":"2021","journal-title":"Beyoglu Eye J."},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.oret.2020.08.007","article-title":"Suprachoroidal CLS-TA plus Intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study","volume":"5","author":"Barakat","year":"2021","journal-title":"Ophthalmol. Retin."},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000489345","article-title":"Sequential dexamethasone and aflibercept treatment in patients with diabetic macular edema: structural and functional outcomes at 52 weeks","volume":"241","author":"Hern\u00e1ndez-Bel","year":"2019","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00417-017-3819-2","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema","volume":"256","author":"Yu","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10792-017-0496-4","article-title":"Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial","volume":"38","author":"Riazi-Esfahani","year":"2018","journal-title":"Int Ophthalmol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106904_bib54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3928\/23258160-20170829-08","article-title":"Multicenter, randomized clinical trial to assess the effectiveness of intravitreal injections of bevacizumab, triamcinolone, or their combination in the treatment of diabetic macular edema","volume":"48","author":"Neto","year":"2017","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"issue":"5","key":"10.1016\/j.phrs.2023.106904_bib55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10384-016-0458-9","article-title":"Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema","volume":"60","author":"Shimura","year":"2016","journal-title":"Jpn J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/jop.2015.0092","article-title":"Combined intravitreal ranibizumab and sub-tenon injection of triamcinolone for the treatment of diabetic macular edema with retinal detachment","volume":"32","author":"Ercalik","year":"2016","journal-title":"J. Ocul. Pharm. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2023.106904_bib57","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/IAE.0000000000000533","volume":"35","author":"Maturi","year":"2015","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib58","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/IAE.0b013e31822f55de","article-title":"Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema","volume":"32","author":"Soheilian","year":"2012","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.phrs.2023.106904_bib59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000331935","article-title":"Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial","volume":"227","author":"Lim","year":"2012","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib60","first-page":"352","article-title":"Intravitreal bevacizumab combined with\/without triamcinolone acetonide in single injection for treatment of diabetic macular edema","volume":"124","author":"Wang","year":"2011","journal-title":"Chin. Med J. (Engl. )"},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib61","first-page":"841","article-title":"Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema","volume":"35","author":"Synek","year":"2011","journal-title":"Coll. Antropol."},{"key":"10.1016\/j.phrs.2023.106904_bib62","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/OPTH.S22103","article-title":"Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema","volume":"5","author":"Marey","year":"2011","journal-title":"Clin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib63","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ophtha.2009.01.011","article-title":"Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema","volume":"116","author":"Soheilian","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/112067210801800614","article-title":"Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema","volume":"18","author":"Faghihi","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib65","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00417-007-0688-0","article-title":"Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial","volume":"246","author":"Ahmadieh","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106904_bib66","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/IAE.0b013e31815ec261","article-title":"Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema","volume":"27","author":"Soheilian","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.phrs.2023.106904_bib67","unstructured":"Clearside Biomedical, I., Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema. 2017, \u3008https:\/\/ClinicalTrials.gov\/show\/NCT03126786\u3009."},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib68","article-title":"Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema","volume":"4","author":"Mehta","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2023.106904_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245010","article-title":"Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression","volume":"16","author":"Abdel-Maboud","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.phrs.2023.106904_bib70","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","article-title":"A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study","volume":"121","author":"Gillies","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.phrs.2023.106904_bib71","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/IAE.0000000000003080","article-title":"Long-term incidence and risk factors of ocular hypertension following dexamethasone-implant injections: the safodex-2 study","volume":"41","author":"Rezkallah","year":"2021","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.phrs.2023.106904_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ophtha.2008.10.002","article-title":"Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection","volume":"116","author":"Roth","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib73","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ajo.2007.12.010","article-title":"Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study","volume":"145","author":"Inatani","year":"2008","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106904_bib74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ophtha.2021.11.024","article-title":"The 12- and 24-month effects of intravitreal ranibizumab, aflibercept, and bevacizumab on intraocular pressure: a network meta-analysis","volume":"129","author":"Nanji","year":"2022","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106904_bib75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.phrs.2023.106904_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence","volume":"48","author":"Sim\u00f3","year":"2015","journal-title":"Prog. Retin Eye Res"},{"issue":"6","key":"10.1016\/j.phrs.2023.106904_bib77","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"van Dijk","year":"2012","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2023.106904_bib78","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2009.165662","article-title":"Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME","volume":"94","author":"Nunes","year":"2010","journal-title":"Br. J. Ophthalmol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:45:00Z","timestamp":1760913900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":78,"alternative-id":["S1043661823002608"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106904","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106904"}}